473596-87-1

Basic information

• Product Name: 4-(Methoxycarbonyl)-2-methylphenylboronic acid pinacol ester
• Synonyms: 4-(Methoxycarbonyl)-2-methylphenylboronic acid pinacol ester;2-Methyl-4-methoxycarbonylphenylboronic acid, pinacol ester;3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-Benzoic acid methyl ester;Methyl 3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)
• CAS NO: 473596-87-1
• Molecular Formula: C₁₅H₂₁BO₄
• Molecular Weight: 276.14
• Product Categories: Aryl;Organoborons
• Mol File: 473596-87-1.mol
• Article Data: 21

Chemical Properties

• Boiling Point: 377.5±35.0 °C(Predicted)
• Appearance: /
• Density: 1.07±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 4-(Methoxycarbonyl)-2-methylphenylboronic acid pinacol ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(Methoxycarbonyl)-2-methylphenylboronic acid pinacol ester(473596-87-1)
• EPA Substance Registry System: 4-(Methoxycarbonyl)-2-methylphenylboronic acid pinacol ester(473596-87-1)

Safety Data

• Hazardous Substances Data: 473596-87-1(Hazardous Substances Data)

Usage

General Description

4-(Methoxycarbonyl)-2-methylphenylboronic acid pinacol ester is a chemical compound commonly used in organic synthesis and medicinal chemistry. It is a boronic acid derivative with a pinacol ester group and a methoxycarbonyl moiety attached to a phenyl ring. 4-(Methoxycarbonyl)-2-methylphenylboronic acid pinacol ester is often utilized in the formation of carbon-carbon and carbon-heteroatom bonds, as well as in the construction of complex organic molecules. It is also used in the development of pharmaceuticals and agrochemicals due to its versatile reactivity and ability to participate in various chemical reactions. Overall, 4-(Methoxycarbonyl)-2-methylphenylboronic acid pinacol ester is an important building block in organic chemistry with a wide range of applications.

Upstream product

• 148547-19-7 4-Bromo-3-methylbenzoic acid methyl ester 
• 73183-34-3 bis(pinacol)diborane 
• 171364-80-0 methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate 
• 67-56-1 methanol 
• 269409-74-7 3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid 
• 91367-05-4 methyl 4-chloro-3-methylbenzoate 

Downstream Products

• 1008770-59-9 3-methyl-4-(3-trifluoromethylpyridin-2-yl)benzoic acid methyl ester 
• 158429-38-0 (4-(methoxycarbonyl)-2-methylphenyl)boronic acid 
• 1140462-11-8 C₁₅H₁₅NO₂ 
• 1201908-23-7 methyl 4'-butoxy-3'-{[2-fluoro-4-(trifluoromethyl)phenylamido]methyl}-2-methylbiphenyl-4-carboxylate 
• 1254328-48-7 methyl 4-(3-amino-6-(3,4,5-trimethoxyphenyl)pyrazin-2-yl)-3-methylbenzoate 
• 1279107-83-3 Ethyl 2-(2-chlorophenyl)-5-(4-(methoxycarbonyl)-2-methylphenyl)-1H-indole-1-carboxylate 
• 1300696-22-3 methyl 4-[(2S,4R)-1-acetyl-2-methyl-4-({[(1-methylethyl)oxy]carbonyl}amino)-1,2,3,4-tetrahydro-6-quinolinyl]-3-methylbenzoate 
• 1033244-94-8 C₁₉H₂₀N₄O₂ 
• 1033244-95-9 C₁₈H₁₈N₄O₂ 
• 1033243-63-8 C₂₂H₂₈N₆O 
• 1279104-65-2 4-[2-(2-chloro-phenyl)-1H-indol-5-yl]-3-methyl-benzoic acid methyl ester 
• 1279104-67-4 4-[2-(2-chloro-phenyl)-1H-indol-5-yl]-3-methyl-benzamide 
• 1279106-98-7 4-[2-(2-chloro-phenyl)-1H-indol-5-yl]-3-methyl-benzoic acid 
• 1279104-66-3 4-[2-(2-chloro-phenyl)-1H-indol-5-yl]-3,N-dimethyl-benzamide 

Relevant articles and documents

Cholesteryl ester transfer protein (CETP) inhibitors based on cyclic urea, bicyclic urea and bicyclic sulfamide cores

Cholesteryl ester transfer protein (CETP) inhibitors reduce the transfer of cholesteryl esters from the high-density lipoprotein (HDL-C) to apolipoprotein such as VLDL/LDL, with exchange of triglycerides. Thus, this inhibition increases the HDL-C levels, which is believed to lower the risk for heart disease and stroke. We report here a series of CETP inhibitors based on the cyclic, bicyclic urea and sulfamide cores. These CETP inhibitors exemplified by 15, 31, and 45 demonstrated in vitro potency in inhibiting the CETP transfer activity, and 15, 31 showing in vivo efficacy to increase HDL-C levels in cynomolgus-CETP transgenic mice. The synthesis and biological evaluations of these CETP inhibitors are described.

Luminescent tungsten(vi) complexes as photocatalysts for light-driven C-C and C-B bond formation reactions

The realization of photocatalysis for practical synthetic application hinges on the development of inexpensive photocatalysts which can be prepared on a large scale. Herein an air-stable, visible-light-absorbing photoluminescent tungsten(vi) complex which can be conveniently prepared at the gram-scale is described. This complex could catalyse photochemical organic transformation reactions including borylation of aryl halides, such as aryl chloride, reductive coupling of benzyl bromides for C-C bond formation, reductive coupling of phenacyl bromides, and decarboxylative coupling of redox-active esters of alkyl carboxylic acid with high product yields and broad functional group tolerance.

Small molecule compound

The invention provides a small molecular compound, The small molecular compound is characterized by having a structure as shown in the following molecular general formula, wherein X1 and X2 are selected from carbon or nitrogen, G1 is a carbon ring or a heterocyclic ring with aromaticity, any one or more hydrogen atoms on the G1 ring are substituted by R1, wherein R1 is selected from nitrogen-containing groups. The small molecule compound can be used as an efficient and specific JAK kinase inhibitor, especially a Tyk2 inhibitor, and/or a JAK1 inhibitor, and/or a JAK1/Tyk2 dual inhibitor, or a Tyk2/JAK1 dual inhibitor or a Tyk2/Jak2 dual inhibitor.